SCHEMBL27517650

SCHEMBL27517650

O=C(O)c1cccc(Cc2nnc(-c3cccnc3)o2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMO O15229 1/20 0.54
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ RAB9A P51151 3/20 0.51
▸ RXFP1 Q9HBX9 1/20 0.51
▸ NPC1 O15118 2/20 0.50
▸ HPGD P15428 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ GPR55 Q9Y2T6 1/20 0.50
▸ FAAH O00519 1/20 0.48
▸ CES1 P23141 1/20 0.48
▸ KDM4E B2RXH2 3/20 0.47
▸ POLB P06746 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ LMNA P02545 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ EGFR P00533 2/20 0.47
▸ HTT P42858 2/20 0.46
▸ PKM P14618 1/20 0.45
▸ MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2710881 0.79 RAB9A (0.51) SMN1; SMN2RAB9ARXFP1NPC1HPGD
SCHEMBL13403930 0.77 KMO (0.59) KMOHTTALDH1A1GAA
SCHEMBL27500508 0.75 SMN1; SMN2 (0.55) SMN1; SMN2RAB9ARXFP1NPC1HPGD
SCHEMBL12797730 0.74 NPC1 (0.73) KMOSMN1; SMN2RAB9ANPC1HPGD
SCHEMBL27516586 0.74 RAB9A (0.58) SMN1; SMN2RAB9ARXFP1NPC1HPGD
SCHEMBL12797794 0.74 HDAC6 (0.52) SMN1; SMN2RAB9ARXFP1NPC1HPGD
SCHEMBL2436535 0.73 HDAC6 (0.76) SMN1; SMN2RAB9ANPC1HPGDTSHR
SCHEMBL5640575 0.73 RAB9A (0.71) SMN1; SMN2RAB9ARXFP1NPC1HPGD
SCHEMBL29569537 0.72 KMO (1.00) KMOL3MBTL1MKNK1MKNK2MEN1
SCHEMBL206541 0.72 KMO (1.00) KMOL3MBTL1MKNK1MKNK2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1740169-B Arylmethylamine derivatives for use as tryptase inhibitors AVENTIS PHARMA INC 2010-04-21 — — CN disclosed
CN-1740169-A Arylmethylamine derivatives for use as tryptase inhibitors AVENTIS PHARMA INC (US) 2006-03-01 — — CN disclosed
CN-1230431-C Arylmethylamine derivatives useful as tryptase inhibitors AVENTIS PHARM PROD INC (US) 2005-12-07 — — CN disclosed
CN-1439003-A Arylmethylamine derivatives useful as tryptase inhibitors AVENTIS PHARM PROD INC (US) 2003-08-27 — — CN disclosed
Send feedback